Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

Open Access

8 February 2012

journal article
Published by Springer Nature in BMC Infectious Diseases

Vol. 12 (1) , 35
https://doi.org/10.1186/1471-2334-12-35

Abstract

The first meningococcal serogroup C (MenC) conjugate vaccine was licensed in 1999 and introduced in the United Kingdom. Countries that have implemented the MenC vaccine since then in their national immunisation programmes use different schedules. Nevertheless, all involved countries seem to experience substantial declines in the incidence of MenC disease.

Keywords

This publication has 18 references indexed in Scilit:

Meningococcal glycoconjugate vaccines
Human Vaccines, 2011
Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign
Acta Paediatrica, 2010
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
BMJ, 2008
Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003–2005
European Journal of Clinical Microbiology & Infectious Diseases, 2008
Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
The Journal of Infectious Diseases, 2008
Serogroup C Meningococcal Glycoconjugate Vaccine in Adolescents: Persistence of Bactericidal Antibodies and Kinetics of the Immune Response to a Booster Vaccine More Than 3 Years after Immunization
Clinical Infectious Diseases, 2006
Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: A model-based evaluation
Vaccine, 2006
Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom
Infection and Immunity, 2003
Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England
Clinical and Vaccine Immunology, 2003
Immunosurveillance and the evaluation of national immunization programmes: a population-based approach
Epidemiology and Infection, 1998